COR Therapeutics Lowered

Also: opinions on Target Corp. and Heinz

COR Therapeutics (CORR ): Downgraded to 3 STARS (hold) from 5 STARS (buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.